ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Upton May Leave NCI Soon, Newell Accepts Post At M.D. Anderson to Head Cancer Prevention

August 17, 1979

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

Nobel Laureate Baruch Blumberg Dies at 85

April 8, 2011

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991

NCI Not Following Congress Mandate, Zubrod Contends

April 28, 1978